Modified sanjiasan decoction in regulating intelligence state of patients with vascular dementia.
- Author:
Tao LIU
1
;
Can-hui WANG
;
Jin YANG
Author Information
- Publication Type:Clinical Trial
- MeSH: Aged; Dementia, Vascular; drug therapy; Female; Humans; Intelligence; drug effects; Intelligence Tests; Male; Materia Medica; therapeutic use; Middle Aged; Nootropic Agents; therapeutic use; Phytotherapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2005;25(6):492-495
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the therapeutic effects of modified Sanjiasan decoction (MSD) on vascular dementia (VD).
METHODSThirty-seven patients in the treated group were given MSD, one dosage each day, and 31 patients in the control group were administered orally Naofukang 0.8 g three times a day. The treatment course for both groups was three months. The indices as Hasegawa dementia scale (HDS), mini mental state examination (MMSE) and its subentries, intelligence quotient (IQ) and memory quotient (MQ) were examined.
RESULTSMSD could improve the scores of HDS, MMSE and its subentries (P<0.05 or P<0.01), ameliorate dementia state and enhance IQ (P<0.05) and MQ (P<0.01) in patients with VD.
CONCLUSIONMSD has a certain effect on intelligence benefiting and dementia antagonizing.
